Hi roughie, first post on this forum but I have been following Clarity for sometime now and believe it displays all the necessary fundamentals to make a much higher Market Capitalisation . I think the rival Australian company that is now commercialised is a basic blueprint for Cu6 ultimate outcome.
As for an analysis of the chart of Clarity I would use Stan Weinstein's description of similar shaped charts, I believe he would describe it as a thing of beauty.
it absolutely perfectly fits his 4 stage analysis trading strategy. Looking at the daily chart over the last year the chart is approaching a base or stage 1 it is well below the 50 SMA and 200SMA, of stage 4 and both moving averages are at the moment coming to an apex .
All things being equal the 50day should dip down to travel just above the share price action eventually possibly seesawing below and above the daily share price. Eventually the expectation would be the share price would breakout above the 50 day moving average and move above its most recent points of resistance. The 50mday would be just moving up again. Stan, I think would regard this as the best place to buy in and the chart would be in stage 2 . How long it takes the chart to do this is anybody's guess, might only be a couple of weeks to a few months.
Considering what's in the pipeline I would hope no later that the end of this quarter, just my guess though. It appears from my own experience of having the torch applied to my toes and the comments of others more experienced, (but it's just my opinion), the team that runs the show is equally or more important than the product, its vital they get to commercialisation and net profit as soon as possible and minimise credit raises in the interim. If anyone has anything further to add I would welcome the response.
- Forums
- ASX - By Stock
- CU6
- CU6 - ASX Charts
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
5.44%
!
$2.52

CU6 - ASX Charts, page-1505
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.52 |
Change
0.130(5.44%) |
Mkt cap ! $810.1M |
Open | High | Low | Value | Volume |
$2.39 | $2.54 | $2.37 | $5.141M | 2.072M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6820 | $2.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.52 | 3500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6820 | 2.500 |
1 | 6415 | 2.490 |
2 | 26415 | 2.480 |
2 | 7915 | 2.470 |
4 | 41204 | 2.450 |
Price($) | Vol. | No. |
---|---|---|
2.520 | 3500 | 1 |
2.530 | 1000 | 1 |
2.540 | 41066 | 4 |
2.550 | 30570 | 7 |
2.560 | 6415 | 1 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online